The patient interest is also interesting. If you look at the Inspire website which is a patient portal for clinical trials, conditions, advances.... there has been an upsurge in threads, discussions about the VB-111 trial.... several new patients enrolled in last few weeks; as opposed to little interest last year or in the first three months of '16. Sure this is anecdotal evidence, but it corresponds with what Harats said on the last few conference calls. I think they could be fully enrolled by year end.
News 
Market Data 
Discover 
